FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 312:1282-1287 May 16, 1985 Number 20 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To distinguish metabolic from genetic factors in the development of microangiopathy in diabetes, we evaluated biopsy specimens of kidney and quadriceps muscle from seven pairs of identical twins who were discordant for Type I (insulin-dependent) diabetes mellitus. Two of the diabetic patients had clinical diabetic nephropathy, including hypertension, marked albuminuria, and a substantially reduced creatinine clearance; the other five had normal renal function and only minor clinical indications of complications. All the twins of the diabetic patients had normal glomerular basement membrane widths and normal fractional volumes of the glomerular mesangium. Values for glomerular basement membrane width, tubular basement membrane width, and mesangial volume in each diabetic twin exceeded the values in the respective sibling (P less than or equal to 0.0035), even if the value in the diabetic twin lay within established normal ranges. Values for muscle capillary basement membrane width in the diabetic twins did not differ from those in their siblings (P = 0.5). Our observations suggest that the metabolic abnormalities of diabetes are necessary, if not sufficient, for the development of glomerular abnormalities. We also conclude that in diabetic patients, alterations in muscle capillary basement membrane width do not necessarily accompany pathologic lesions in the kidney.

This article has been cited by other articles:

• Fioretto, P., Bruseghin, M., Berto, I., Gallina, P., Manzato, E., Mussap, M. (2006). Renal Protection in Diabetes: Role of Glycemic Control. J. Am. Soc. Nephrol. 17: S86-S89 [Abstract] [Full Text]  
• Caramori, M. L., Fioretto, P., Mauer, M. (2006). Enhancing the Predictive Value of Urinary Albumin for Diabetic Nephropathy. J. Am. Soc. Nephrol. 17: 339-352 [Abstract] [Full Text]  
• Klein, R., Zinman, B., Gardiner, R., Suissa, S., Donnelly, S. M., Sinaiko, A. R., Kramer, M. S., Goodyer, P., Moss, S. E., Strand, T., Mauer, M. (2005). The Relationship of Diabetic Retinopathy to Preclinical Diabetic Glomerulopathy Lesions in Type 1 Diabetic Patients: The Renin-Angiotensin System Study. Diabetes 54: 527-533 [Abstract] [Full Text]  
• Drummond, K., Mauer, M. (2002). The Early Natural History of Nephropathy in Type 1 Diabetes: II. Early Renal Structural Changes in Type 1 Diabetes. Diabetes 51: 1580-1587 [Abstract] [Full Text]  
• Fioretto, P., Steffes, M. W., Sutherland, D. E.R., Goetz, F. C., Mauer, M. (1998). Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation. NEJM 339: 69-75 [Abstract] [Full Text]  
• RIZZA, R. A. (1986). New Modes of Insulin Administration: Do They Have a Role in Clinical Diabetes?. ANN INTERN MED 105: 126-129 [Abstract]